NRAGE promotes the malignant phenotype of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a fatal disease, primarily due to the limited effective therapies available for patients with advanced or recurrent stages of the disease. Therefore, in order to improve patient prognosis, it is important to identify an informative biomarker for HCC progression, as...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: SHIMIZU, DAI, KANDA, MITSURO, SUGIMOTO, HIROYUKI, SUEOKA, SATOSHI, TAKAMI, HIDEKI, EZAKA, KAZUHIRO, TANAKA, YURI, HASHIMOTO, RYOJI, OKAMURA, YUKIYASU, IWATA, NAOKI, TANAKA, CHIE, YAMADA, SUGURU, FUJII, TSUTOMU, NAKAYAMA, GORO, KOIKE, MASAHIKO, NOMOTO, SHUJI, FUJIWARA, MICHITAKA, KODERA, YASUHIRO
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2016
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774420/
https://ncbi.nlm.nih.gov/pubmed/26998088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4120
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia